Invited by Prof. Shengli Yang (academician of Chinese Academy of Engineering), the president of Shanghai Biotecan Pharmaceuticals Co., Ltd., Dr. Jingwei Lou visited DICP, CAS on May. 6-7.
After Dr. Lou had a lab tour in some research groups of Biotechnology Department the scientific workshop was held in the Biotechnology building conference hall presided by Prof. Yang. Dr. Lou briefly introduced the basic status of Shanghai Biotecan Pharmaceuticals Co., Ltd. Subsequently, Prof. Guowang Xu gave a brief talk on Biotechnology Department and metabolomics applications in translational medicine. After that, Profs. Zhen Liang, Fangjun Wang, Hai-long Piao, Yang Liu, Guangwei Sun, Jianhua Qin, Guangbo Ge and Xingya Xue showed the platform development in DICP and translational medicine applications. The host and guest also discussed the topics of common interest and made a rough framework for bilateral cooperation in the future.
President of Shanghai Biotecan Pharmaceuticals Co., Ltd., Dr. Jingwei Lou visited DICP (Image by Hailong Piao)
This workshop aims to make use of the advantage of the techniques in DICP, to cooperate with domestic first-class Pharmaceuticals Co., Ltd. to solve clinical problems. It can be expected that this kind of communication will promote applications of metabolomics, proteomics, microfluidic chip, drug R/D etc. in translational medicine. (Text/Image by Hailong Piao).